About

Over the last 25 years, GlobalReach BI has developed a focused and strong methodology to support the pharmaceutical industry in their strategic intelligence with high value secondary and primary intelligence. Industry experts and CI Professionals are part of GlobalReach Bi to make sure our client partners are provided with the most appropriate insights for decision making process, either in developing new drugs across clinical stages or launching treatments around the world.
The addition of OpenAI to SPRING Platform allows you to draw analysis based on your bespoke intelligence generated from conferences or regular market monitoring.
GlobalReach BI is committed to excellence and innovation, enabling AI technology across its Strategic Intelligence services.